Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Soluble Fms-Like Tyrosine Kina...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.

Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.

Bibliographic Details
Main Authors: Verlohren, S, Herse, F, Pape, J, Hering, L, Wenzel, K, Luft, F, Wallukat, G, Dudenhausen, J, Redman, C, Dechend, R
Format: Journal article
Published: 2008
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
    by: Herse, F, et al.
    Published: (2009)
  • Soluble Fms-like tyrosine cinase 1 (sFLt-1) and antibody against AT1-receptor in preclempsia a comparison in a blind study design
    by: Verlohren, S, et al.
    Published: (2008)
  • CORRELATION BETWEEN FMS-LIKE TYROSINE KINASE-1 (SFLT-1) CELL-FREE MESSENGER RNA EXPRESSION AND FMS-LIKE TYROSINE KINASE-1 (SFLT-1) PROTEIN LEVEL IN SEVERE PREECLAMPSIA AND NORMAL PREGNANCY
    by: Jeffry Iman Gurnadi, et al.
    Published: (2015-09-01)
  • Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
    by: Laura Ehrlich, et al.
    Published: (2017-04-01)
  • Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
    by: Natalie J. Hannan, et al.
    Published: (2017-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs